Centers of Excellence for Translational Research (CETR) (U19)

The purpose of this grant is to solicit applications from single institutions or a consortium of institutions to participate in the Centers for Excellence in Translational Research (CETR) program. This program will support multidisciplinary translational research Centers focused on generating, validating, and advancing medical countermeasures against the following bacteria or fungi with known and emerging resistance to current therapies.

Bacteria

• Acinetobacter baumannii
• Campylobacter spp.
• Clostridioides difficile
• Enterobacter spp.
• Enterococcus spp.
• Escherichia coli
• Klebsiella pneumoniae
• Neisseria gonorrhoeae
• Non-tuberculous mycobacteria (NTM)
• Nontyphoidal Salmonella spp.
• Pseudomonas aeruginosa
• Salmonella enterica serovar
• Typhi Shigella spp.
• Staphylococcus aureus
• Streptococcus pneumoniae

Fungi

• Aspergillus fumigatus
• Candida spp., in particular C. auris

It is expected that NIAID will grant 4-5 awards.

Funding: $5,000,000 per year

Duration: 5 years

Research Authority due date: 20.3.24

LIO (encouraged) due date: 29.3.24

Full proposal due date: 27.4.24